These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19068786)

  • 21. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of resistance and mobility among multidrug-resistant CTX-M-producing Escherichia coli from Canadian intensive care units: the 1st report of QepA in North America.
    Baudry PJ; Nichol K; DeCorby M; Lagacé-Wiens P; Olivier E; Boyd D; Mulvey MR; Hoban DJ; Zhanel GG
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):319-26. PubMed ID: 19216943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addressing the challenge of extended-spectrum beta-lactamases.
    Zahar JR; Lortholary O; Martin C; Potel G; Plesiat P; Nordmann P
    Curr Opin Investig Drugs; 2009 Feb; 10(2):172-80. PubMed ID: 19197795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
    Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
    J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic detection of extended-spectrum beta-lactamase-containing Escherichia coli isolates and vancomycin-resistant enterococci in fecal samples of healthy children.
    Guimarães B; Barreto A; Radhouani H; Figueiredo N; Gaspar E; Rodrigues J; Torres C; Igrejas G; Poeta P
    Microb Drug Resist; 2009 Sep; 15(3):211-6. PubMed ID: 19728780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on integrons in Escherichia coli which producing extended-spectrum beta-lactamases, isolated from stool specimen of chicken].
    Li JY; Cui SH; Zhang L; Hu CQ; Jin SH; Ma Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1020-3. PubMed ID: 19173888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
    Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
    Arpin C; Quentin C; Grobost F; Cambau E; Robert J; Dubois V; Coulange L; André C;
    J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
    Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
    J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First report on the occurrence of SHV-12 extended-spectrum beta-lactamase-producing Enterobacteriaceae in the Philippines.
    Cabrera EC; Rodriguez RD
    J Microbiol Immunol Infect; 2009 Feb; 42(1):74-85. PubMed ID: 19424562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing bacteria in intensive care units of Sanandaj general hospitals (Kurdistan, Iran).
    Ramazanzadeh R; Chitsaz M; Bahmani N
    Chemotherapy; 2009; 55(4):287-92. PubMed ID: 19521074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal.
    Mendonça N; Ferreira E; Louro D; ; Caniça M
    Int J Antimicrob Agents; 2009 Jul; 34(1):29-37. PubMed ID: 19272757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India.
    Behera B; Mathur P; Das A; Kapil A
    Singapore Med J; 2009 Jun; 50(6):628-32. PubMed ID: 19551319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Shi WF; Zhou J; Qin JP
    Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged fecal shedding of CTX-M-15-producing Escherichia coli and recurrent sepsis in a patient after cord blood stem-cell transplantation.
    Huang KY; Chia JH; Chiang CY; Wu TL; Su LH; Jaing TH; Lin TY; Chiu CH
    Scand J Infect Dis; 2009; 41(3):224-7. PubMed ID: 19116886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spread of CTX-M-type extended-spectrum beta-lactamases among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae from a Korean hospital.
    Lee SG; Jeong SH; Lee H; Kim CK; Lee Y; Koh E; Chong Y; Lee K
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):76-80. PubMed ID: 19073302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
    Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTX-M type beta-lactamases among fecal Escherichia coli and Klebsiella pneumoniae isolates in non-hospitalized children and adults.
    Ho PL; Wong RC; Chow KH; Yip K; Wong SS; Que TL
    J Microbiol Immunol Infect; 2008 Oct; 41(5):428-32. PubMed ID: 19122926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.